Fate Therapeutics, Inc.
US ˙ NasdaqGM ˙ US31189P1021

SecurityFATE / Fate Therapeutics, Inc.
InstitutionDimensional Fund Advisors Lp
Latest Disclosed Ownership883,790 shares
Latest Disclosed Value $ 1,060,068
Dimensional Fund Advisors Lp reports 43.97% decrease in ownership of FATE / Fate Therapeutics, Inc.

On May 7, 2026 - Dimensional Fund Advisors Lp filed a 13F-HR form disclosing ownership of 883,790 shares of Fate Therapeutics, Inc. (US:FATE) valued at $1,060,548 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 1,577,478 shares of Fate Therapeutics, Inc.. This represents a change in shares of -43.97% during the quarter. The current value of the position is $1,749,904 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F FATE THERAPEUTICS COM 31189P102 883,790 -693,688 -43.97 1,060 -31.61 0.0002
2026-02-12 2025-12-31 13F FATE THERAPEUTICS COM 31189P102 1,577,478 -517,497 -24.70 1,550 -41.22 0.0003
2025-11-12 2025-09-30 13F FATE THERAPEUTICS COM 31189P102 2,094,975 -342,754 -14.06 2,638 -3.37 0.0006
2025-08-12 2025-06-30 13F FATE THERAPEUTICS COM 31189P102 2,437,729 -153,829 -5.94 2,730 33.32 0.0006
2025-05-13 2025-03-31 13F FATE THERAPEUTICS COM 31189P102 2,591,558 -306,819 -10.59 2,048 -57.19 0.0005
2025-02-13 2024-12-31 13F FATE THERAPEUTICS COM 31189P102 2,898,377 279,360 10.67 4,782 -47.83 0.0011
2024-11-07 2024-09-30 13F FATE THERAPEUTICS COM 31189P102 2,619,017 488,737 22.94 9,167 31.20 0.0022
2024-08-09 2024-06-30 13F FATE THERAPEUTICS COM 31189P102 2,130,280 1,067,101 100.37 6,987 -10.46 0.0018
2024-05-10 2024-03-31 13F FATE THERAPEUTICS COM 31189P102 1,063,179 742,405 231.44 7,804 550.25 0.0021
2024-02-07 2023-12-31 13F FATE THERAPEUTICS COM 31189P102 320,774 -394,375 -55.15 1,200 -20.84 0.0004
2023-11-09 2023-09-30 13F FATE THERAPEUTICS COM 31189P102 715,149 510,423 249.32 1,516 55.65 0.0005
2023-08-09 2023-06-30 13F FATE THERAPEUTICS COM 31189P102 204,726 -144,803 -41.43 975 -51.08 0.0003
2023-05-12 2023-03-31 13F FATE THERAPEUTICS COM 31189P102 349,529 -201,940 -36.62 1,992 39,720.00 0.0007
2023-02-09 2022-12-31 13F FATE THERAPEUTICS COM 31189P102 551,469 311,787 130.08 6 -99.91 0.0016
2022-11-10 2022-09-30 13F FATE THERAPEUTICS COM 31189P102 239,682 -27,484 -10.29 5,371 -18.87 0.0021
2022-08-12 2022-06-30 13F FATE THERAPEUTICS COM 31189P102 267,166 -121,950 -31.34 6,620 -56.12 0.0024
2022-05-13 2022-03-31 13F FATE THERAPEUTICS COM 31189P102 389,116 -25,361 -6.12 15,088 -37.79 0.0046
2022-02-09 2021-12-31 13F FATE THERAPEUTICS COM 31189P102 414,477 95,408 29.90 24,254 28.25 0.0073
2021-11-12 2021-09-30 13F FATE THERAPEUTICS COM 31189P102 319,069 191,004 149.15 18,912 70.12 0.0061
2021-08-12 2021-06-30 13F FATE THERAPEUTICS COM 31189P102 128,065 63,303 97.75 11,117 107.52 0.0035
2021-05-14 2021-03-31 13F FATE THERAPEUTICS COM 31189P102 64,762 32,404 100.14 5,357 82.09 0.0018
2021-03-08 2020-12-31 13F/A-2 FATE THERAPEUTICS COM 31189P102 32,358 32,358 2,942 0.0011
2021-02-11 2020-12-31 13F FATE THERAPEUTICS COM 31189P102 32,358 32,358 2,942 1,062.4940
2020-11-12 2020-09-30 13F FATE THERAPEUTICS COM 31189P102 0 -22,771 -100.00 0 -100.00
2020-08-13 2020-06-30 13F FATE THERAPEUTICS COM 31189P102 22,771 0 0.00 781 54.35 0.0003
2020-05-14 2020-03-31 13F FATE THERAPEUTICS COM 31189P102 22,771 -1,229 -5.12 506 7.66 0.0003
2020-02-14 2019-12-31 13F FATE THERAPEUTICS COM 31189P102 24,000 24,000 470 0.0002
2018-11-13 2018-09-30 13F FATE THERAPEUTICS COM 31189P102 0 -23,500 -100.00 0 -100.00
2018-08-10 2018-06-30 13F FATE THERAPEUTICS COM 31189P102 23,500 0 0.00 266 16.16 0.0001
2018-05-11 2018-03-31 13F FATE THERAPEUTICS COM 31189P102 23,500 0 0.00 229 59.03 0.0001
2018-02-12 2017-12-31 13F FATE THERAPEUTICS COM 31189P102 23,500 0 0.00 144 54.84 0.0001
2017-11-13 2017-09-30 13F FATE THERAPEUTICS COM 31189P102 23,500 0 0.00 93 22.37 0.0000
2017-08-11 2017-06-30 13F FATE THERAPEUTICS COM 31189P102 23,500 23,500 76 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.